These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 30348020

  • 1. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells.
    Pindiprolu SKSS, Chintamaneni PK, Krishnamurthy PT, Ratna Sree Ganapathineedi K.
    Drug Dev Ind Pharm; 2019 Feb; 45(2):304-313. PubMed ID: 30348020
    [Abstract] [Full Text] [Related]

  • 2. Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer.
    Ss Pindiprolu SK, Krishnamurthy PT, Ghanta VR, Chintamaneni PK.
    Nanomedicine (Lond); 2020 Jul; 15(16):1551-1565. PubMed ID: 32618501
    [Abstract] [Full Text] [Related]

  • 3. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer.
    Pindiprolu SKSS, Krishnamurthy PT, Dev C, Chintamaneni PK.
    Chem Phys Lipids; 2021 Mar; 235():105033. PubMed ID: 33385372
    [Abstract] [Full Text] [Related]

  • 4. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T, Sudhakar G, Marepally S, Patel A, Banerjee R, Singh M.
    Mol Pharm; 2015 Apr 06; 12(4):1105-20. PubMed ID: 25661724
    [Abstract] [Full Text] [Related]

  • 5. Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer.
    Chaudhuri A, Naveen Kumar D, Kumar D, Kumar Agrawal A.
    Eur J Pharm Biopharm; 2024 Aug 06; 201():114386. PubMed ID: 38950717
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer.
    Wang W, Chen T, Xu H, Ren B, Cheng X, Qi R, Liu H, Wang Y, Yan L, Chen S, Yang Q, Chen C.
    Molecules; 2018 Jun 29; 23(7):. PubMed ID: 29966245
    [Abstract] [Full Text] [Related]

  • 10. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H, Rompicharla SVK, Komanduri N, Aashma S, Paradkar S, Ghosh B, Biswas S.
    Curr Drug Deliv; 2018 Jun 29; 15(9):1271-1283. PubMed ID: 29732970
    [Abstract] [Full Text] [Related]

  • 11. Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In vitro.
    Eskiler GG, Cecener G, Dikmen G, Egeli U, Tunca B.
    Curr Drug Deliv; 2019 Jun 29; 16(6):511-529. PubMed ID: 31113350
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimization of atorvastatin and quercetin-loaded solid lipid nanoparticles using Box-Behnken design.
    Lalchandani DS, Chenkual L, Sonpasare K, Rajdev B, Naidu V, Chella N, Porwal PK.
    Nanomedicine (Lond); 2024 Jul 14; 19(17):1541-1555. PubMed ID: 39012199
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
    Rompicharla SVK, Bhatt H, Shah A, Komanduri N, Vijayasarathy D, Ghosh B, Biswas S.
    Chem Phys Lipids; 2017 Nov 14; 208():10-18. PubMed ID: 28842128
    [Abstract] [Full Text] [Related]

  • 16. Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.
    Khurana RK, Kumar R, Gaspar BL, Welsby G, Welsby P, Kesharwani P, Katare OP, Singh KK, Singh B.
    Mater Sci Eng C Mater Biol Appl; 2018 Oct 01; 91():645-658. PubMed ID: 30033299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles.
    Talluri SV, Kuppusamy G, Karri VV, Yamjala K, Wadhwani A, Madhunapantula SV, Pindiprolu SS.
    Artif Cells Nanomed Biotechnol; 2017 May 01; 45(3):474-488. PubMed ID: 27112220
    [Abstract] [Full Text] [Related]

  • 19. Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies.
    Sabapati M, Palei NN, C K AK, Molakpogu RB.
    Drug Dev Ind Pharm; 2019 Apr 01; 45(4):577-586. PubMed ID: 30663427
    [Abstract] [Full Text] [Related]

  • 20. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
    Lee MK, Lim SJ, Kim CK.
    Biomaterials; 2007 Apr 01; 28(12):2137-46. PubMed ID: 17257668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.